Rebates

Primary care rebate schemes (PCRS) are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s).

The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Any decision to accept a PCRS is only made once a clinical decision to approve the use of a medication has been agreed locally.

We are unable to publish the full details of the PCRS because this information is commercially sensitive.

Although there are a number of PCRS available, NHS Waltham Forest CCG are signed up to the following:

Rebate Scheme Name

Drugs Covered

Companies Involved

Start Date

End Date

Aymes CCG Commercial Proposition

Aymes oral nutritional supplements

Aymes

Apr-19

Mar-20  (automatic renewal until agreement terminated by either party)

Carbocisteine 750mg/10ml sugar-free oral solution in sachet

Carbocisteine

Intapharm Laboratories Limited

Mar-16

Apr-20

Simple Rebate scheme Firmagon

Degarelix

Ferring Pharmaceuticals

Apr-19

Aug-19 (renewal pending)

Reletrans (Buprenorphine) 7 day transdermal  patches scheme

Buprenorphine 7 day patch

Sandoz

Sep-16

Aug-20

Zaluron XL (Quetiapine XL)

Quetiapine XL

Fontus Health Ltd

Apr-19

Mar-24

Glaxosmithkline UK limited-GSK

Seretide Accuhaler and Evohaler

Glaxosmithkline UK Limited (GSK)

Jun-17

Jun-20

Rebate agreement for Sitagliptan (Januvia)

Sitaliptan

Merck Sharp & Dohme limited

May-19

Apr-20